Company
Headquarters: Fuzhou, China
Employees: 708
CN¥15.11 Billion
CNY as of Jan. 1, 2026
US$2.15 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers Chinese patent medicines in the areas of liver diseases, andrology, cardiovascular, and other fields. The company was founded in 2001 and is based in Fuzhou, China.
| Last Financial Reports Date | June 30, 2025 |
| Revenue TTM | CN¥431.0 M |
| EBITDA | CN¥41.6 M |
| Gross Profit TTM | CN¥235.3 M |
| Profit Margin | -45.77% |
| Operating Margin | -24.33% |
| Quarterly Revenue Growth | -1.10% |
Fujian Cosunter Pharmaceutical Co. Ltd has the following listings and related stock indices.
Stock: SZSE: 300436